During the past decade, University of Debrecen, Medical and Health Science Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 10 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Debrecen, Medical and Health Science Center" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Biotronik SE & Co. KG" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Henogen" with 2 trials sponsored and "Octapharma" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Debrecen, Medical and Health Science Center" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator, "American College of Rheumatology" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Cardialysis BV" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "University of Debrecen, Medical and Health Science Center" are "Acute Myocardial Infarction" (2 trials), "Asthma" (2 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Coronary Artery Disease" (2 trials) and "Hepatitis B" (2 trials). Many other conditions were trialed in "University of Debrecen, Medical and Health Science Center" in a lesser frequency.

Most popular intervention types in "University of Debrecen, Medical and Health Science Center" are "Drug" (21 trials), "Biological" (4 trials), "Device" (3 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Rituximab" (5 trials), "Bendamustine" (2 trials), "Bevacizumab" (2 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Debrecen, Medical and Health Science Center" are 30 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Debrecen, Medical and Health Science Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in University of Debrecen, Medical and Health Science Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of Debrecen, Medical and Health Science Center, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".